Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.12 USD | -4.94% | -5.68% | -34.04% |
Apr. 15 | Intellia Therapeutics, Inc. Appoints Michael P. Dube as Principal Accounting Officer | CI |
Mar. 25 | Intellia Therapeutics Ends Development Agreement With Regeneron Pharmaceuticals | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.04% | 2.04B | |
+1.34% | 43.84B | |
+6.80% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+7.18% | 25.53B | |
-24.47% | 18.18B | |
-3.48% | 12.29B | |
+26.64% | 12.29B | |
+7.30% | 11.15B |
- Stock Market
- Equities
- NTLA Stock
- News Intellia Therapeutics, Inc.
- Sector Update: Health Care Stocks Drifting Lower Near Friday Close